Empirico

Empirico is a well-funded, innovative pharmaceutical company established to harness extensive biological data, human genetics, and adaptable biology for the purpose of driving original target exploration and advancement. The Precision Insights Platform of Empirico was specially developed for uncovering treatments and utilizes a globally leading information collection and sophisticated algorithmic methods to recognize and prioritize treatment targets with a strong likelihood of successful application. Prominent treatment targets undergo in-house experimental validation before progressing through preclinical development using the most effective treatment approach.